Highlights of Developments in the Stock Market Agenda (November 19, 2025)

Important Company Developments

#A1CAP – The company has applied to the Capital Markets Board (CMB) for the issuance of debt instruments up to 10 billion TL. This step stands out as a strategy aimed at strengthening its financial resources.

Investments in Medical and Industrial Hemp

#AGROT – The company announced that it has started acquisition negotiations with a company engaged in the production of medical and industrial hemp. This move aims to diversify the company’s portfolio and achieve growth.

Share Sale and Capital Increase

#ALVES – Deniz Karamercan reported the disposal of 6 million shares at a price of 28.00 TL to the Stock Exchange. Additionally, an application has been made to MKK for these shares to be traded on the Stock Exchange.

#GEDIK – The company decided to increase its registered capital ceiling from 3 billion TL to 6 billion TL. This significant step will create a financing source that supports the company's growth strategy.

Important Projects and Contracts

#EKGYO – The company successfully completed the first session of the tender for revenue sharing from land sales in Aydın Didim Fevzipaşa. Additionally, a preliminary contract for an important housing project was signed with its subsidiary.

#TAVHL – The company announced that it has successfully completed the merger process with its wholly-owned subsidiary TAV Esenboğa Investment, taking an important step towards growth.

Loan Agreements and Debt Instruments

#GARAN – The bank signed a credit agreement with ICO for a total of 100 million dollars with a maturity of up to 10 years. This will strengthen its financial resources.

#CRDFA – The company decided to issue debt instruments up to 180 million TL, while it made a decision to cancel the sale of a Mercedes Benz S 450 d 4 Matic L model vehicle. These developments will show their impact on the markets.

#PNSUT – The company issued a bond worth 200 million TL with a maturity of 70 days, which will create an important source for its cash flow.